Source:http://linkedlifedata.com/resource/pubmed/id/17291492
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0010749,
umls-concept:C0026237,
umls-concept:C0030685,
umls-concept:C0031164,
umls-concept:C0035647,
umls-concept:C0071174,
umls-concept:C0205100,
umls-concept:C0205263,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1705165,
umls-concept:C1751130,
umls-concept:C1963578,
umls-concept:C2700061
|
pubmed:issue |
2-3
|
pubmed:dateCreated |
2007-3-9
|
pubmed:abstractText |
Mitochondrial permeability transition pore plays an important role in the processes of cell apoptosis and necrosis. The peripheral benzodiazepine receptor, a mitochondria outer-membrane protein, is involved in the regulation of mitochondrial permeability transition. In the present study, we test if PK11195, a peripheral benzodiazepine receptor ligand, can lead to the opening of mitochondrial permeability transition pores, and subsequently causes mitochondria cytochrome c loss and mitochondria uncoupling. In isolated cardiac mitochondria, PK11195 (50, 100, 200 microM) caused a dose-dependent mitochondrial swelling, cytochrome c loss, and the dissipation of mitochondrial potential. Cyclosporin A (0.2 microM), a specific inhibitor of mitochondrial permeability transition, completely prevented the mitochondrial swelling induced by PK11195, and maintained the cytochrome c content and membrane potential. These data suggest that peripheral benzodiazepine receptor ligand, PK11195 caused mitochondrial uncoupling and cytochrome c loss via induction of mitochondrial permeability transition.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytochromes c,
http://linkedlifedata.com/resource/pubmed/chemical/GABA-A Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Isoquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Membrane Transport...,
http://linkedlifedata.com/resource/pubmed/chemical/PK 11195,
http://linkedlifedata.com/resource/pubmed/chemical/mitochondrial permeability...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
560
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
117-22
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17291492-Animals,
pubmed-meshheading:17291492-Cytochromes c,
pubmed-meshheading:17291492-Dose-Response Relationship, Drug,
pubmed-meshheading:17291492-GABA-A Receptor Antagonists,
pubmed-meshheading:17291492-Isoquinolines,
pubmed-meshheading:17291492-Male,
pubmed-meshheading:17291492-Membrane Potentials,
pubmed-meshheading:17291492-Mitochondria,
pubmed-meshheading:17291492-Mitochondrial Membrane Transport Proteins,
pubmed-meshheading:17291492-Mitochondrial Swelling,
pubmed-meshheading:17291492-Rats,
pubmed-meshheading:17291492-Rats, Sprague-Dawley
|
pubmed:year |
2007
|
pubmed:articleTitle |
Peripheral benzodiazepine receptor ligand, PK11195 induces mitochondria cytochrome c release and dissipation of mitochondria potential via induction of mitochondria permeability transition.
|
pubmed:affiliation |
Department of Anesthesiology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China. jnyuanli@163.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|